Universal Biosensors poised for sale
10 September, 2010 by David BinningThe retirement this week of Mark Morrisson as the CEO of Australian medical diagnostics company Universal Biosensors has triggered speculation throughout the industry that the company may be on the market.
Top Qld researcher receives funding boost for leukaemia work
10 September, 2010 by Staff WritersProfessor Geoff Hill, chair of immunology at the Queensland Institute of Medical Research (QIMR), has been awarded a second round Senior Clinical Research Fellowships (SCRF) from the Queensland Government to support his work on improving bone marrow transplant success for leukaemia sufferers.
Long-term study on childhood cancer released
09 September, 2010 by Staff WritersIt wasn’t so long ago that a diagnosis of cancer in children was an almost certain death sentence. Nowadays more than 80 percent of affected children survive into later life and beyond. However, with this greater life expectancy comes an increased risk of a recurrance of the initial cancer, secondary cancers and a host of other debilitating health conditions.
European researchers report major new malaria breakthrough
07 September, 2010 by Staff WritersEuropean researchers have identified an exciting new drug candidate which has shown to be effective against common malaria parasites including drug-resistant strains of the virus.
Drug screening robot comes to the rescue for kids with cancer
03 September, 2010 by Staff WritersThe Children’s Cancer Institute Australia for Medical Research (CCIA) has received $3.1 million to fund a new drug screening robot designed to radically improve the understanding and treatment of cancer in children.
Study links metals imbalance with Alzheimer’s
03 September, 2010 by David BinningScientists from Australia and the US have published the results of a study linking an imbalance of metals in the brain with Alzheimer's disease.
New protein points to possible Alzheimer’s cure
02 September, 2010 by David BinningAn 84-year old American Nobel Laureate has discovered a new protein which observers are saying may herald a completely new approach to treating Alzheimer’s disease.
Bionomics anxiety drug could be more effective than valium
31 August, 2010 by Staff WritersAdelaide biotech Bionomics has presented the results of preclinical and clinical data for its anti-anxiety compound BNC210, demonstrating that the drug is more effective in treating stressed rats than the current market leader valium (Diazapem).
Under-arm license delivers maiden FY profit for Acrux
27 August, 2010 by Staff WritersTestosterone booster Acrux this week stormed into the black for the first time, announcing a net profit of $46.6 million after earlier in the year signing one of the biggest ever multinational licensing deals for an Australian biotech.
Feature: Fighting cancer with proteomics
19 August, 2010 by Fiona WylieWho would have thought that a staid structural part of the cell could be so treacherous in cancer, determining life or death? Maria Kavallaris at Children’s Cancer Institute Australia is using a mixture of proteomics and good old-fashioned biology to fight such treachery head-on.
Specialised Therapeutics announces success of compassionate cancer program
18 August, 2010 by David BinningA compassionate program run by Melbourne biotech Specialised Therapeutics (STA) has helped more than 240 Australian cancer patients to benefit from a world-leading new treatment based on nanoparticles, the company said.
Study sheds new light on relationship between obesity and diabetes
17 August, 2010 by Staff WritersScientists at the Walter and Eliza Hall Institute (WEHI) have completed a study showing that cells which lead to inflammation in fat tissue may be a primary cause of insulin resistance in sufferers of diabetes.
Mesoblast progressing towards Phase III bone marrow trial in US
16 August, 2010 by Staff WritersRegenerative medicine specialists Mesoblast today announced that it has provided market guidance to the FDA regarding its Phase 3 bone marrow transplantation program, which it hopes will create more options for patients as well as a reduction in incidences of graft-versus-host disease (GVHD).
Feature: Xenotransplantation offers hope to diabetes sufferers
16 August, 2010 by Fiona WylieBack when Living Cell Technologies's (LCT) current Medical Director and Founder, Professor Bob Elliott, was working in his Auckland clinic, he decided that the treatments available for patients with Type I diabetes simply weren't good enough.
New study to turn cancer research on its head
02 August, 2010 by David BinningResearchers at the Walter and Eliza Hall Institute (WEHI) have shown that programmed cell death or apoptosis, a process which has typically been assumed to prevent or slow the development of cancer, may in some instances contribute to its spreading.
